Analyst Price Targets — BLND
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 11, 2026 12:32 pm | Karl Keirstead | UBS | $2.00 | $1.82 | TheFly | Blend Labs price target lowered to $2 from $3 at UBS |
| March 3, 2025 11:29 am | — | Canaccord Genuity | $5.25 | $2.97 | TheFly | Blend Labs price target lowered to $5.25 from $5.75 at Canaccord |
| August 12, 2024 4:01 am | Joseph Vafi | Canaccord Genuity | $4.75 | $3.66 | StreetInsider | Canaccord Genuity Upgrades Blend Labs (BLND) to Buy |
| November 14, 2022 9:09 am | — | Canaccord Genuity | $3.00 | $2.20 | Benzinga | Canaccord Genuity Maintains Hold on Blend Labs, Lowers Price Target to $3 |
| April 19, 2022 10:04 am | — | Goldman Sachs | $7.00 | $5.00 | Benzinga | Goldman Sachs Maintains Buy on Blend Labs, Lowers Price Target to $7 |
| January 25, 2022 12:00 am | Josh Beck | KeyBanc | $10.00 | $7.22 | Pulse 2.0 | Blend Labs Stock (BLND): Why The Price Went Down Today |
Latest News for BLND
Shares of Blend Labs, Inc. (NYSE: BLND - Get Free Report) have been given a consensus recommendation of "Hold" by the seven research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
I'm downgrading Blend Labs to Sell due to mortgage industry headwinds and the moderate potential for disruption risk from GenAI-enabled competitors. BLND trades at a slight EV/Sales premium (3.4x) despite negative revenue growth estimates and a challenging demand outlook. Management is focused on cash preservation, operating profitability, and AI integration, but faces shareholder dilution and high CapEx relative to…
Blend Labs Inc (NYSE: BLND) reported mixed results for the fourth quarter on Tuesday.
Blend Labs, Inc. (BLND) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BLND.
U.S. House Trading
No House trades found for BLND.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.